In contrast, tan IIA arrests the cell cycle in lung cancer at the G0/G1 phase via upregulating the levels of p53 and p21 as well as downregulating the levels of cyclin D1, cyclin E1, and cyclin-dependent kinase 2 (CDK2) (Lee et al., 2016). Here, CCND1 is linked to lung carcinoma.